Skip to main content
. 2024 Dec 13;14:30460. doi: 10.1038/s41598-024-82115-1

Fig. 8.

Fig. 8

Anti-proliferative activity of HPCR on normal cells; human dermal fibroblast (HDF) and cancerous cell lines including breast cancer (MCF-7), non-small cell lung cancer (A549) and glioblastoma (U-87 MG). Cells were treated with HPCR at various concentrations ranging from 1–1000 μM for 96 h.